Clinical Trials Directory

Trials / Completed

CompletedNCT01702259

Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.

A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia Scanner Device (GLS) Green Diode on Reducing the Appearance of Cellulite Clinical Study Protocol.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Erchonia Corporation · Industry
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether the application of green diode low level laser light therapy is effective in reducing the appearance of cellulite in the thighs and buttocks.

Detailed description

Cellulite is a common term used to describe superficial pockets of trapped fat, which causes uneven dimpling or "orange peel" skin. It appears in 90% of post-adolescent women. In advanced stages of cellulite, heaviness and pain may occur. Currently available treatments for cellulite have minimal to no demonstrable effect and some involve risky invasive procedures. Therefore, the potential advantages of the application of low level laser light therapy to reduce the appearance of cellulite over current treatment options include a risk free procedure that is non-invasive and pain free. Since low level laser light within the green spectrum has been proven to increase the synthesis of collagen, it is believed that its application may serve to decrease the appearance of cellulite by tightening the skin. Moreover, newly synthesized collagen may alter the irregular pattern of the connective tissue responsible for the formation of cellulite.

Conditions

Interventions

TypeNameDescription
DEVICEErchonia Scanner device (GLS)The Erchonia® GLS device is made up of six independent diodes, each emitting 17 milliwatts (mW), 532 nanometer (nm) of green laser light.
DEVICEPlacebo deviceInactive Erchonia GLS.

Timeline

Start date
2009-10-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2012-10-08
Last updated
2015-12-11
Results posted
2015-12-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01702259. Inclusion in this directory is not an endorsement.